Navigation Links
BrainCells Inc. Appoints David E. Thompson to Its Board of Directors
Date:12/2/2008

SAN DIEGO, Dec. 2 /PRNewswire/ -- BrainCells Inc. (BCI), a biopharmaceutical company utilizing its platform technology to identify and develop compounds that promote the growth of new neurons for the treatment of central nervous system (CNS) diseases, announced today the appointment of David E. Thompson to its board of directors. Thompson is a veteran of the pharmaceutical industry, with a 30-year tenure at Eli Lilly and Co. where he focused on building the company while leading corporate strategy, business development, corporate ventures and alliance management.

"Dave is an industry veteran with broad experience and numerous relationships in the pharmaceutical and biotech world," said Jim Schoeneck, BrainCells CEO. "He will be a valuable resource as we execute corporate strategy and potential transactions around our neurogenesis platform technology and compounds in clinical development, including BCI-540, for which we anticipate Phase II data for the treatment of depression and anxiety in 2009."

Thompson conducted a successful 30-year career at Eli Lilly and its affiliates which culminated in a position as vice president of corporate strategy and business development. During his tenure at Eli Lilly, Thompson focused his expertise on all aspects of Lilly's business, holding numerous positions including director of corporate new product planning and licensing, president and general manager of Eli Lilly Canada, president/CEO of IVAC Corporation and vice president of pharmaceutical product management and licensing. Currently, Thompson is executive chairman of Bayhill Therapeutics, Inc. and is a member of the board of directors for Anthera Pharmaceuticals, Inc. Born in Lansing, Michigan, he is a graduate of Michigan State University with a BS and MBA.

"BCI's scientific application of neurogenesis for the treatment of mood disorders and other CNS diseases has the potential to revolutionize th
'/>"/>

SOURCE BrainCells Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. REVISED: BrainCells Inc. Expands Series B Financing to $50 Million
2. BrainCells Inc. Expands Series B Financing to $50 Million
3. BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
4. Cerimon Pharmaceuticals Appoints James S. Shannon, M.D., to Board of Directors
5. Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America
6. InCode BioPharmaceutics Appoints New President and CEO
7. Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
8. GeneNews appoints Canadian Colorectal Cancer Advisory Board
9. WuXi PharmaTech Appoints Ying Han to Its Board of Directors
10. TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors
11. Accumetrics Appoints John J. Young, MD Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) today announced ... Officer has resigned.  The Company has hired Andrew ... in December 2014, as full time interim CFO and ... Andy Ashworth began his employment today, ... transition.  Andy was the Company,s CFO from September 2011 ...
(Date:7/29/2015)... ... July 29, 2015 , ... G-CON Manufacturing, Inc., the leading ... 2nd generation cell therapy POD® design. The 2nd generation portfolio not only delivers ... new POD® design. , “G-CON first offered our miniPOD CT product line ...
(Date:7/29/2015)...  AmnioChor Inc., an early stage biotech startup based ... announce that the Musculoskeletal Transplant Foundation of ... their seed round of development of the proprietary AmnioCept™ ... AmnioChor,s technology allows cryopreservation of the amniotic ... living within those tissues. Amnion is a well-established source ...
(Date:7/29/2015)... July 29, 2015  Indivior PLC (LON: INDV) today ... nasal spray was accepted and received Priority Review by ... treatment of opioid overdose. This naloxone nasal spray comes ... for optimal absorption into the nasal mucosa. 1 ... so individuals may be better equipped to help an ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5
... regulatory approvals for the $2.3 billion acquisition of Instrumentarium ... of two divisions of the company they are acquiring. ... plans to integrate Instrumentarium it into its GE ... Dow Wilson.. , ,The final required regulatory ...
... Network ready to air a sitcom set in mythical Waterford ... prime-time televisions limelight whether it wants to or not. ... stars Norm Macdonald of Saturday Night Live and Norm fame, ... review of the show makes it sound like a neurotic ...
... MADISON, WI - Even as the State Assembly Ways and ... -- a measure that would end state and local sales ... was passing a measure that, if it becomes law, would ... passed H.R. 49 , which would permanently extend an ...
Cached Biology Technology:Maybe its time to write our own television shows about Wisconsin 2State and Feds Race to Stop Taxation of Internet Access 2State and Feds Race to Stop Taxation of Internet Access 3State and Feds Race to Stop Taxation of Internet Access 4
(Date:7/31/2015)... The 10 th International Conference on Genomics ... 22-25, 2015, in Shenzhen , ... 10 th anniversary this year. Since its inauguration in ... annual meetings in the ,omics, fields, and is one of ... ICG-10 focuses on recent breakthroughs and advances in ,omics, ...
(Date:7/23/2015)... July 23, 2015 Aware, Inc. (NASDAQ: AWRE ... reported financial results for its second quarter ended June 30, ... 2015 was $4.5 million, a decrease of 33% compared to ... in the second quarter of 2015 was $0.3 million, or ... $0.04 per diluted share, in the same period a year ...
(Date:7/21/2015)... 21, 2015 Passwords have proven futile ... the recent U.S. Office of Personnel Management breach. ... infosec conundrum, but developers and end-users are concerned ... this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced today ... for third party integration. A ...
Breaking Biology News(10 mins):The 10th International Conference on Genomics (ICG-10) to Open in October 2Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4
... ZambiaAccording to a report issued last week by UNAIDS, ... mortality worldwide. But Dr. Groesbeck Parham, gynecologic oncologist ... the Center for Infectious Disease Research in Zambia (CIDRZ) ... up dying of cervical cancer unless they have access ...
... of the Eastern Virginia Medical School today announced that it ... Melinda Gates Foundation to develop microbicides for HIV prevention. ... $65 million to CONRAD for microbicide research. ... research on novel and improved in vitro and small-animal models ...
... new x-ray technique that could be used to detect hidden ... Cernik and colleagues from The School of Materials have built ... each point of an image to be clearly identified. ... The Journal of the Royal Society Interface and is published ...
Cached Biology News:Women with AIDS face cervical cancer threat 2CONRAD receives $28.5M Gates Foundation grant for HIV prevention research 2New X-ray technique targets terrorists and tumors 2
SpectroQuest single beam 1.8nm UV/Vis spectrophotometer; stand-alone unit...
...
... The CopyControl™ PCR Cloning Kits are designed to ... ensure that all PCR products, regardless of sequence ... All PCR products including those that are difficult ... that may be unstable or code for potentially ...
... Cloning Kit, 40 reactions. Optimized for ... all PCR products with blunt or ... by offering consistently better signal-to-noise ratios ... positive clones.Amplicons generated by proof-reading thermostable ...
Biology Products: